Overview

Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the efficacy of MAL + Aktilite versus placebo + Aktilite in facial photodamage in a randomized double blind trial.
Phase:
Phase 3
Details
Lead Sponsor:
Universidad de Antioquia
Collaborators:
Galderma
Galderma R&D
Treatments:
Aminolevulinic Acid
Methyl 5-aminolevulinate